开发新的糖尿病患者低血糖健康相关生活质量量表:Hypo-RESOLVE QoL
该混合方法项目通过半结构化访谈(N=31)、三轮认知访谈(N=70例糖尿病患者,N=14名临床医生)和大规模横断面调查(N=1246)开发了Hypo-RESOLVE QoL量表。最终量表含14个条目,结构效度、聚合效度、内部一致性和重测信度均满意。作者认为该量表可用于临床决策和作为临床试验终点。
要点
- Hypo-RESOLVE QoL为14条目量表,评估低血糖对健康相关生活质量的影响。
- 量表内部一致性α=0.91,重测信度组内相关系数=0.87。
- 作者认为该量表可用于临床决策和作为临床试验终点。
核心结论
- Hypo-RESOLVE QoL是严格开发的评估低血糖健康相关生活质量影响的患者报告结局量表,具有可证明的效度和信度,作者认为其可用于临床决策和作为临床试验终点。
研究设计与样本
- 混合方法项目,分三阶段:阶段1半结构化访谈(N=31);阶段2三轮认知访谈(N=70例糖尿病患者,N=14名临床医生);阶段3大规模横断面观察性调查(N=1246)。
主要发现
- 构建了包含19个主题的低血糖相关健康相关生活质量概念模型,按躯体、社会和心理方面组织。
- 从76条目草案最终形成14条目量表,结构效度满意(χ2=472.27,df=74,p<0.001;比较拟合指数=0.943;近似误差均方根=0.069)。
- 与相关构念的聚合效度r=0.46-0.59,内部一致性α=0.91,重测信度组内相关系数=0.87。
临床怎么用
- 作者认为Hypo-RESOLVE QoL可用于临床决策和作为临床试验终点。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Valid and reliable patient-reported outcome measures are vital for assessing disease impact, responsiveness to healthcare and the cost-effectiveness of interventions. A recent review has questioned the ability of existing measures to assess hypoglycaemia-related impacts on health-related quality of life for people with diabetes. This mixed-methods project was designed to produce a novel health-related quality of life patient-reported outcome measure in hypoglycaemia: the Hypo-RESOLVE QoL. METHODS: Three studies were conducted with people with diabetes who experience hypoglycaemia. In Stage 1, a comprehensive health-related quality of life framework for hypoglycaemia was elicited from semi-structured interviews (N=31). In Stage 2, the content validity and acceptability of draft measure content were tested via three waves of cognitive debriefing interviews (N=70 people with diabetes; N=14 clinicians). In Stage 3, revised measure content was administered alongside existing generic and diabetes-related measures in a large cross-sectional observational survey to assess psychometric performance (N=1246). The final measure was developed using multiple evidence sources, incorporating stakeholder engagement. RESULTS: A novel conceptual model of hypoglycaemia-related health-related quality of life was generated, featuring 19 themes, organised by physical, social and psychological aspects. From a draft version of 76 items, a final 14-item measure was produced with satisfactory structural (χ2=472.27, df=74, p<0.001; comparative fit index =0.943; root mean square error of approximation =0.069) and convergent validity with related constructs (r=0.46-0.59), internal consistency (α=0.91) and test-retest reliability (intraclass correlation coefficient =0.87). CONCLUSIONS/INTERPRETATION: The Hypo-RESOLVE QoL is a rigorously developed patient-reported outcome measure assessing the health-related quality of life impacts of hypoglycaemia. The Hypo-RESOLVE QoL has demonstrable validity and reliability and has value for use in clinical decision-making and as a clinical trial endpoint. DATA AVAILABILITY: All data generated or analysed during this study are included in the published article and its online supplementary files ( https://doi.org/10.15131/shef. DATA: 23295284.v2 ).
引用
- Carlton J, Powell PA, Broadley M, et al. Development of a new health-related quality of life measure for people with diabetes who experience hypoglycaemia: the Hypo-RESOLVE QoL. Diabetologia. 2024. PMID: 38777868. doi:10.1007/s00125-024-06182-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。